• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, July 25, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Medical cannabis use in Australian patients with chronic health issues linked to significant improvements in overall health-related quality of life and fatigue levels

Bioengineer by Bioengineer
September 6, 2023
in Health
Reading Time: 4 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Australian patients with chronic health issues prescribed medical cannabis showed significant improvements in overall health-related quality of life and fatigue in the first three months of use, along with improvements in anxiety, depression, and pain. Interestingly, cannabis therapy did not seem to improve reported sleep disturbances, according to a study published September 6, 2023 in the open-access journal PLOS ONE by Margaret-Ann Tait from the University of Sydney, Australia, and colleagues.

Health-related quality of life in patients accessing medicinal cannabis in Australia: The QUEST initiative results of a 3-month follow-up observational study

Credit: Ard Jongsma (https://stillwords.com/) and owned by Little Green Pharma Denmark, CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/)

Australian patients with chronic health issues prescribed medical cannabis showed significant improvements in overall health-related quality of life and fatigue in the first three months of use, along with improvements in anxiety, depression, and pain. Interestingly, cannabis therapy did not seem to improve reported sleep disturbances, according to a study published September 6, 2023 in the open-access journal PLOS ONE by Margaret-Ann Tait from the University of Sydney, Australia, and colleagues.

Since 2016 in Australia, medical cannabis has been approved for prescription to patients with health conditions unresponsive to other treatment. Tait and colleagues surveyed a group of Australians with chronic health conditions prescribed medical cannabis to better understand any changes in patient-reported outcomes following cannabis treatment in this population.

The authors used survey responses from 2327 Australian patients with chronic health issues prescribed medical cannabis (THC and CBD dissolved in a medium-chain triglyceride (MCT) carrier oil) between November 2020 and December 2021. Patients were surveyed about their self-reported health-related quality of life, pain, sleep, anxiety, and depression prior to beginning cannabis therapy, after two weeks of treatment, then once a month for three months.

63 percent of the surveyed patients were female, with an average age of 51 years (range 18-97 years). The most-reported conditions being treated were chronic pain (69 percent); insomnia (23 percent); anxiety (22 percent); and anxiety/depression (11 percent); half of patients were being treated for more than one condition. Patients reported significant, clinically-meaningful improvements in health-related quality of life and fatigue measurements across the three months surveyed. Patients also reported clinically meaningful reductions in pain and significant improvements for moderate-severe anxiety and depression. However, though many patients were prescribed cannabis for insomnia, there were no overall improvements in patient-reported sleep disturbance.

The authors did not measure adverse effects as part of the study, though 30 patients formally withdrew from the study due to “unwanted side effects”. Regardless, these results suggest medical cannabis may be effective in helping manage previously-untreatable chronic conditions. The authors also note that more research and development of the cannabis oil products used in this study may be needed in order to successfully treat patients with insomnia and sleep disorders.

The authors add: “Within the first three months of medicinal cannabis therapy, participants reported improvements in their health-related quality of life, fatigue, and health conditions associated with anxiety, depression, and pain.”

#####

In your coverage please use this URL to provide access to the freely available article in PLOS ONE: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0290549

Citation: Tait M-A, Costa DS, Campbell R, Norman R, Warne LN, Schug S, et al. (2023) Health-related quality of life in patients accessing medicinal cannabis in Australia: The QUEST initiative results of a 3-month follow-up observational study. PLoS ONE 18(9): e0290549. https://doi.org/10.1371/journal.pone.0290549

Author Countries: Australia

Funding: The University of Sydney received funding from Little Green Pharma Ltd. to support CR and MT to conduct this study. The funder played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; nor in the decision to submit the article for publication. The study was independently investigator-led and all authors had full access to all data (including statistical reports and tables) in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.



Journal

PLoS ONE

DOI

10.1371/journal.pone.0290549

Method of Research

Survey

Subject of Research

Not applicable

Article Title

Health-related quality of life in patients accessing medicinal cannabis in Australia: The QUEST initiative results of a 3-month follow-up observational study

Article Publication Date

6-Sep-2023

COI Statement

The University of Sydney received funding from Little Green Pharma Pty Ltd. to support MT and CR to conduct the submitted work; LW is a paid employee of Little Green Pharma Pty Ltd.; no other relationships or activities that could appear to have influenced the submitted work. All authors have completed the ICMJE uniform disclosure form. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Share12Tweet8Share2ShareShareShare2

Related Posts

Single-Cell Atlas Links Chemokines to Type 2 Diabetes

July 20, 2025
blank

AI Diagnoses Structural Heart Disease via ECG

July 17, 2025

Functional Regimes Shape Soil Microbiome Response

July 17, 2025

Stealth Adaptations in Large Ichthyosaur Flippers

July 17, 2025

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15
  • AI Achieves Breakthrough in Drug Discovery by Tackling the True Complexity of Aging

    70 shares
    Share 28 Tweet 18
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    43 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Additive Manufacturing of Monolithic Gyroidal Solid Oxide Cells

Machine Learning Uncovers Sorghum’s Complex Mold Resistance

Pathology Multiplexing Revolutionizes Disease Mapping

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.